The Immunology Clinical Specialist (ICS) position is responsible for driving demand for the assigned product, CIMZIA® (certolizumab pegol), by reinforcing the clinical features of the product and UCB value within an assigned territory; engaging and building relationships with clinical decision makers and office support staff to create the best experiences for patients living with severe immunologic diseases who are treated in the home care setting.
Additional Preferred Qualifications:
UCB is a global biopharmaceutical company, with a focus on neurology and immunology.
Our business is strong. Total revenue grew to $4.5 billion in 2017. We are more than 7,500 people in all four corners of the globe, inspired by patients and driven by science.
Looking ahead, we have a solid platform for continuous growth with our core products Cimzia®, Vimpat®, Neupro®, Keppra® and Briviact®, and we are preparing the launch of a potential medicine to help patients with osteoporosis. At the same time, we are very excited about the progress in our early research pipeline